Aprotinin in open-heart surgery: background and results in patients having aortocoronary bypass grafts

Fish KJ , Sarnquist FH , van Steennis et al. A prospective, randomised study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations. J Thorac Cardiovasc Surg1986; 91: 436-42.

Teoh KH , Cristakis GT , Weisel RD et al. Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg1988; 96: 332-41.

Salzman EW , Weinstein MJ , Weintraub RM et al . Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med1986; 314: 1402-1406.

van der Salm T. , Ansell JE , Okike ON et al . The role of epsilon amino caproic acid in reducing bleeding after cardiac operations: a double-blind study. J Thorac Cardiovasc Surg1988 ; 95: 538-40.

Del Rossi AJ , Cernairnu AC , Botros S. , Lemole GM , Moore R. Prophylactic treatment of postperfusion bleeding with epsilon amino caproic acid. Chest1989; 96: 27-30.

Horrow JC , Hlavacek J. , Strang MD et al . Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg1990; 90: 70-74.

Royston D. , Bidstrup BP , Taylor KM , Sapsford RN Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet1987; ii: 1289-91.

Fritz H. , Wunderer G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforsch1983; 33(1 ): 4: 479-94.

Kraut E. , Frey EK , Werle E. Über die Inaktivierung des Kallikreins. Hoppe-Seyler's Zeitschrift für Physiologische Chemie1930; 192: 1-21.

Kunitz M. , Northrop JH Isolation from beef pancreas of crystalline trypsinogen, trypsin, atrypsin inhibitor and an inhibitor trypsin compound. Journal of General Physiology1936; 19: 991-1007.

Royston D. , Minty BD , Wallwork J. , Higenbottam T. , Jones JG The effects of surgery with cardiopulmonary bypass on alveolar-capillary barrier function in man. Ann Thorac Surg1985; 40: 133-42.

Royston D. , Braude S. , Nolop KB , Hughes Jmb. 113m Indium protein flux does not reflect degree or outcome in respiratory failure. Am Rev Respir Dis1989; 139: A380.

Royston D. , Fleming JS , Desai JB , Westaby S. , Taylor KM Increased peroxide product generation associated with open heart surgery: evidence for free radical generation. J Thorac Cardiovasc Surg1986; 91 : 759-66.

Braude S. , Nolop KB , Fleming JS , Krausz T. , Taylor KM , Royston D. Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass: association with lung neutrophil sequestration and tissue peroxidation . Am Rev Respir Dis1986; 134: 867-2.

Clasen C. , Jochum M. , Mueller-Esterl W. Feasibility study of very high dose aprotinin in polytrauma patients . In: Schlag G, Redl H eds, First Vienna shock forum: pathophysiological role of mediators and mediator inhibitors in shock . New York: Alan R Liss Inc., 1987: 175-83.

van Oeveren W. , Jansen NJ , Bidstrup BP et al. Effects of aprotinin on haemostatic mechanisms during cardiopulmonary bypassAnn Thorac Surg1987; 44: 640-45.

Bidstrup BP , Royston D. , Sapsford RN , Taylor KM Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol)J Thorac Cardiovasc Surg1989; 97: 364-72.

Fraedrich G. , Weber C. , Bernard A. , Hettwer A. , Schlosser V. Reduction of blood transfusion requirement in open heart surgery by administration of high dose aprotinin-preliminary results. Thorac Cardiovasc Surg1989 ; 37: 89-91.

Dietrich W. , Barankay A. , Dilthey G. et al . Reduction in homologous blood requirement in cardiac surgery by intraoperative aprotinin application clinical experience in 152 cardiac surgical patients . Thorac Cardiovasc Surg1989; 37: 92-98.

van Oeveren W. , Harder MP , Roozendaal KJ , Eijsman L. , Wildervuur Crh. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass . J Thorac Cardiovasc Surg: in press.

National Institutes of Health. Perioperative red cell transfusion. National Institutes of Health Consensus Development Conference Statement, 1988: 7(4).

Hannekum A. , Reuter HD , Dalichau H. , Horpacsy C. , Selbherr J. Arilage und zusammenfassendes Ergebnis einer klinischen Doppelblindstudie bei Operationen am offenen Herzen. Einfluss von Aprotinin auf Thrombozytenzahl und -funktion. In: Dudziak et al. eds, Proteolyse und Proteinasen-inhibition in der Herz- und Gefässchirurgie . Stuttgart, New York: Schattauer, 1985: 222-33.

Popov-Cenic S. , Murday H. , Kirchhoff PG , Hack G. , Fenyes J. Anlage und zusammenfassendes Ergebnis einer klinischen Doppelblindstudie bei aorto-koronaren Bypass-Operationen . In: Dudziak et al. eds, Proteolyse und Proteinasen-inhibition in der Herz- und Gefässchirurgie. Stuttgart, New York: Schattauer, 1985: 171-86.

Murday H. , Orellano L. , Fenyes J. , Popov-Cenic S. , Kirchoff PG Sind postoperative Blutungen in der Herzchirurgie durch Behandlung mit Aprotinin bzw.C1 inhibitor vermeidbar?Thorac Cardiovasc Surg1984; 44: 88.

Royston D. The serine antiprotease aprotinin (Trasylol): a novel approach to reduce postoperative bleeding. Coagulation and Fibrinolysis; in press.

Neuhaus P. , Bechstein WO , Lefebre O. , Blumhart G. , Slema K. Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation. Lancet1989 ; ii: 924-25.

Dietrich W. , Jochum M. , Schramm W. , Blü mel G. , Richter JA Reduction of homologous blood requirement in cardiac surgery using high dose aprotinin . Anesthesiology1989; 71 (Supp): A7.

Royston D. , Bidstrup BP , Taylor KM , Sapsford RN Reduced blood loss following open heart surgery with aprotinin (Trasylol) is associated with an increase in intraoperative ACT. J Cardiothorac Anesth1989; 3(Supp 1): 80.